The company has developed a medical device that can detect abnormalities in red blood cells morphology or rigidity, which are indicators of various diseases and conditions such as blood coagulation disorders, malignant homeopathies, malaria, and hereditary anemias. With a sample as small as a drop of blood, RheoDx can measure the behavior of blood in motion and provide results in less than five minutes. Its compact size and user-friendly design allow it to be used both at the point-of-care and at home, empowering patients to conduct tests and improve their quality of life. RheoDx is a diagnostics company dedicated to enhancing the clinical management and quality of life for hematology patients. It originated as a spin-off of the Centre Recerca Matemàtica (CRM) and is now part of the Collider, the tech transfer venture builder supported by the Mobile World Capital Foundation.